Search Results - Baskoy, Gozde

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Empagliflozin Reduces Liver Fat in Diabetic and Nondiabetic Subjects

    Empagliflozin Reduces Liver Fat in Diabetic and Nondiabetic Subjects by Abdelgani, Siham, Khattab, Ahmed, Adams, John, Baskoy, Gozde, Brown, Marissa, Clarke, Geoff, Larvenenko, Olga, DeFronzo, Ralph A., Abdul-Ghani, Muhammad

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes

    Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes by Cersosimo, Eugenio, Alatrach, Mariam, Solis-Herrera, Carolina, Baskoy, Gozde, Adams, John, Hansis-Diarte, Andrea, Gastaldelli, Amalia, Chavez, Alberto, Triplitt, Curtis, DeFronzo, Ralph A

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patients

    Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patients by Cersosimo, Eugenio, YueJuan, Qin, Baskoy, Gozde, Chavez, Alberto, Barkhordarian, Maryam, Hansis-Diarte, Andrea, Triplitt, Curtis, DeFronzo, Ralph A

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The impact of increased hepatic glucose production caused by empagliflozin on plasma glucose concentration in individuals with type 2 diabetes and nondiabetic individuals

    The impact of increased hepatic glucose production caused by empagliflozin on plasma glucose concentration in individuals with type 2 diabetes and nondiabetic individuals by Abdelgani, Siham, Khattab, Ahmed, Adams, John, Baskoy, Gozde, Triplitt, Curtis, DeFronzo, Ralph A., Abdul‐Ghani, Muhammad

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: